Logo image of ARQQ

ARQIT QUANTUM INC (ARQQ) Stock Fundamental Analysis

NASDAQ:ARQQ - KYG0567U1278 - Common Stock

30.255 USD
+2.45 (+8.83%)
Last: 9/11/2025, 5:40:34 PM
30.15 USD
-0.11 (-0.35%)
After Hours: 9/11/2025, 5:40:34 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to ARQQ. ARQQ was compared to 280 industry peers in the Software industry. While ARQQ seems to be doing ok healthwise, there are quite some concerns on its profitability. ARQQ is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year ARQQ has reported negative net income.
ARQQ had a negative operating cash flow in the past year.
ARQQ had negative earnings in 4 of the past 5 years.
ARQQ had a negative operating cash flow in each of the past 5 years.
ARQQ Yearly Net Income VS EBIT VS OCF VS FCFARQQ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M -60M

1.2 Ratios

ARQQ has a Return On Assets of -204.28%. This is amonst the worse of the industry: ARQQ underperforms 95.36% of its industry peers.
ARQQ's Return On Equity of -461.85% is on the low side compared to the rest of the industry. ARQQ is outperformed by 85.00% of its industry peers.
Industry RankSector Rank
ROA -204.28%
ROE -461.85%
ROIC N/A
ROA(3y)-74.09%
ROA(5y)-45.92%
ROE(3y)-161.53%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ARQQ Yearly ROA, ROE, ROICARQQ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 -100 -200 -300 -400

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for ARQQ so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ARQQ Yearly Profit, Operating, Gross MarginsARQQ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 -5K -10K -15K

More info and screens

5

2. Health

2.1 Basic Checks

ARQQ does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ARQQ has been reduced compared to 1 year ago.
ARQQ has a better debt/assets ratio than last year.
ARQQ Yearly Shares OutstandingARQQ Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 50M 100M 150M
ARQQ Yearly Total Debt VS Total AssetsARQQ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

ARQQ has an Altman-Z score of 4.79. This indicates that ARQQ is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 4.79, ARQQ is in the better half of the industry, outperforming 67.50% of the companies in the same industry.
A Debt/Equity ratio of 0.06 indicates that ARQQ is not too dependend on debt financing.
ARQQ has a Debt to Equity ratio (0.06) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Altman-Z 4.79
ROIC/WACCN/A
WACC9.45%
ARQQ Yearly LT Debt VS Equity VS FCFARQQ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M

2.3 Liquidity

A Current Ratio of 1.94 indicates that ARQQ should not have too much problems paying its short term obligations.
The Current ratio of ARQQ (1.94) is comparable to the rest of the industry.
A Quick Ratio of 1.94 indicates that ARQQ should not have too much problems paying its short term obligations.
ARQQ has a Quick ratio of 1.94. This is in the better half of the industry: ARQQ outperforms 60.71% of its industry peers.
Industry RankSector Rank
Current Ratio 1.94
Quick Ratio 1.94
ARQQ Yearly Current Assets VS Current LiabilitesARQQ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

4

3. Growth

3.1 Past

ARQQ shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 58.58%, which is quite impressive.
The Revenue for ARQQ has decreased by -68.25% in the past year. This is quite bad
EPS 1Y (TTM)58.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%81.47%
Revenue 1Y (TTM)-68.25%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-43.7%

3.2 Future

The Earnings Per Share is expected to grow by 28.24% on average over the next years. This is a very strong growth
ARQQ is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 783.92% yearly.
EPS Next Y28.76%
EPS Next 2Y27.61%
EPS Next 3Y28.24%
EPS Next 5YN/A
Revenue Next Year149.19%
Revenue Next 2Y258.4%
Revenue Next 3Y783.92%
Revenue Next 5YN/A

3.3 Evolution

ARQQ Yearly Revenue VS EstimatesARQQ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 100M 200M 300M
ARQQ Yearly EPS VS EstimatesARQQ Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 0 2 -2 -4 -6

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ARQQ. In the last year negative earnings were reported.
Also next year ARQQ is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ARQQ Price Earnings VS Forward Price EarningsARQQ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ARQQ Per share dataARQQ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -1 -2 -3

4.3 Compensation for Growth

A more expensive valuation may be justified as ARQQ's earnings are expected to grow with 28.24% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y27.61%
EPS Next 3Y28.24%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ARQQ!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ARQIT QUANTUM INC

NASDAQ:ARQQ (9/11/2025, 5:40:34 PM)

After market: 30.15 -0.11 (-0.35%)

30.255

+2.45 (+8.83%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)05-22 2025-05-22/bmo
Earnings (Next)12-03 2025-12-03/amc
Inst Owners13.8%
Inst Owner Change0%
Ins Owners9.89%
Ins Owner ChangeN/A
Market Cap407.84M
Analysts82.86
Price Target53.04 (75.31%)
Short Float %16.92%
Short Ratio1.11
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-131.65%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-79.97%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1391.94
P/FCF N/A
P/OCF N/A
P/B 34.51
P/tB 41.28
EV/EBITDA N/A
EPS(TTM)-3.26
EYN/A
EPS(NY)-1.71
Fwd EYN/A
FCF(TTM)-2.78
FCFYN/A
OCF(TTM)-2.53
OCFYN/A
SpS0.02
BVpS0.88
TBVpS0.73
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -204.28%
ROE -461.85%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-74.09%
ROA(5y)-45.92%
ROE(3y)-161.53%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 1135.84%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.94
Quick Ratio 1.94
Altman-Z 4.79
F-Score3
WACC9.45%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)1331.14%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)58.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%81.47%
EPS Next Y28.76%
EPS Next 2Y27.61%
EPS Next 3Y28.24%
EPS Next 5YN/A
Revenue 1Y (TTM)-68.25%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-43.7%
Revenue Next Year149.19%
Revenue Next 2Y258.4%
Revenue Next 3Y783.92%
Revenue Next 5YN/A
EBIT growth 1Y67.43%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-0.9%
EBIT Next 3Y63.99%
EBIT Next 5YN/A
FCF growth 1Y23.49%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-3.95%
OCF growth 3YN/A
OCF growth 5YN/A